Download the supplement (208 p.) - KCE
Download the supplement (208 p.) - KCE
Download the supplement (208 p.) - KCE
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>KCE</strong> reports vol. 40 APPENDICES Physio<strong>the</strong>rapy 51<br />
The current fit of existing tests for global ICF dimensions is often incomplete for varying pathologies.<br />
This could regard both <strong>the</strong> absence of an exhaustive list of item tests or of overall global scoring<br />
measures. Questions regarding <strong>the</strong> link between scoring outcomes and reimbursement terms remain.<br />
The gain in taxonomic simplicity brought on by globalizing dimension scores would be partially offset<br />
by adding an initial pathology-based classification. As shown in our prospective research <strong>the</strong> ten most<br />
frequent pathologies only accounted for 43,3% of attributed treatment sessions. As some of <strong>the</strong>se<br />
defined pathologies should be fur<strong>the</strong>r subdivided for obvious reasons (e.g. presence of orthopaedic<br />
implants into anatomic categories: hip, knee, etc.) it should be clear that any top-down pathologybased<br />
classification would require a manifold of base categories if some degree of overall real life<br />
exhaustiveness is aspired to.<br />
The general concern for proper coding practices and related scientific relevance of ICF tools also<br />
prevails in a partial coding system.<br />
Following <strong>the</strong> exposed arguments, our conclusion reads that <strong>the</strong> disadvantages full ICF codification as a<br />
reimbursement framework entails, also apply to schemes resorting to partial ICF coding: unmanageable<br />
organisational complexity, scientific uncertainty (at present) and deterioration of ICF tools as clinical<br />
standards.<br />
3. CONCLUSION<br />
As stated by our research most analysed fee-for-service schemes favour an approach based on a rudimentary<br />
classification of pathologies into broad reimbursement categories that correspond to a set number of entitled<br />
treatment episodes. Exceptional patient cases warrant complementary treatment on an ad hoc basis through<br />
additional administrative measures (follow-up prescriptions, etc.). Fur<strong>the</strong>r observed developments regard care<br />
capitation and product bundling. These measures aim to simplify billing procedures and make third-party<br />
expenditures more manageable.<br />
Consequently, observed reimbursement schemes appear to be driven by an impetus toward organisational<br />
simplicity ra<strong>the</strong>r than attested clinical effectiveness. As our discussion on ICF coding aimed to demonstrate,<br />
this approach is justified from a third-party payer perspective. Even more so, applying ICF as a reimbursement<br />
reference could be detrimental to its intrinsic scientific relevance. Therefore, it should be clear that <strong>the</strong><br />
significance of ICF as a policy tool must be restricted to its use as a complementary and strictly scientific<br />
means, in time perhaps helping to fill a crucial void in assuring <strong>the</strong> quality of physio<strong>the</strong>rapy care.